Changes to the website
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4639

Next 25
Website Changes
07/27/2015 Gadolinium-based Contrast Agents for Magnetic Resonance Imaging (MRI): Drug Safety Communication - FDA Evaluating the Risk of Brain Deposits With Repeated Use
07/27/2015 A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
07/18/2015 Hyperbaric oxygen promotes malignant glioma cell growth and inhibits cell apoptosis.
07/18/2015 ReACT: Overall Survival From a Randomized Phase II Study of Rindopepimut (CDX-110) Plus Bevacizumab in Relapsed Glioblastoma.
07/18/2015 The Efficacy of Ketogenic Diet and Associated Hypoglycemia as an Adjuvant Therapy for High-Grade Gliomas: A Review of the Literature.
07/18/2015 Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort.
07/13/2015 Ottawa Hospital launches world`s first clinical trial of double-virus cancer treatment
07/13/2015 FDA Grants Fast Track Designation to Tocagen’s Toca 511 & Toca FC for Treatment of Recurrent High Grade Glioma
07/06/2015 Epigenetic Driver of Glioblastoma Provides New Therapeutic Target
07/06/2015 An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas.
07/05/2015 Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.
07/05/2015 Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
07/01/2015 Tocagen June 2015 Newsletter
06/27/2015 Problem with our websites and email
06/27/2015 IBTA Newsletter
06/23/2015 FEATURED ON THE CERN-FOUNDATION WEB SITE, A BOOK ABOUT BRAIN TUMORS RASIES FUNDS FOR RESEARCH. WRITTEN BY A BRAIN TUMOR SRVIVIOR, A POINGNANT STORY OF A FAMILY STRUGGLING WITH BRAIN CANCER.
06/20/2015 New City Of Hope Clinical Trial Harnesses The Power Of The Immune System To Fight Brain Cancers
06/18/2015 Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics
06/13/2015 Free summer camp in NJ - Camp Jinka
06/05/2015 The Musella Foundation announced that it has awarded Tocagen Inc. a grant to support preclinical testing the compatibility of Tocagen’s therapy with 5-ALA or tumor treating fields.
06/04/2015 Blaze Bioscience Announces Open Enrollment for Phase 1 Clinical Trial of Tumor Paint BLZ-100 in Children with Brain Cancer
06/03/2015 Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.
06/03/2015 Randomized Phase 2 ReACT Study of RINTEGA(R) in Recurrent Bevacizumab-naive Glioblastoma Demonstrates Statistically Significant Overall Survival and Emergence of Long-term Survival Benefit; Primary Endpoint of PFS6 Met
05/31/2015 Novocure Announces First Analysis of Full 700 Patient Dataset from Successful Newly Diagnosed GBM Phase III Trial
05/31/2015 MUSELLA FOUNDATION AWARDS 6 BRAIN TUMOR RESEARCH GRANTS



Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2015 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites